HEPATITIS C AND PULMONARY FIBROSIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ALIANNEZHAD R.; GHANEEI MOSTAFA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2011 | Volume:11 | Issue:2 (31) Page(s): 71-73

Download Full-Text

View:

341

Download:

253

Cites:

Information Journal Paper

Title

HEPATITIS C AND PULMONARY FIBROSIS

Author(s)

ALIANNEZHAD R. | GHANEEI MOSTAFA | Issue Writer Certificate

Keywords

HEPATITIS C

PULMONARY FIBROSIS

Abstract

Background: HEPATITIS C virus (HCV) is a hepatotropic and lymphotropic virus that causes hepatic and extrahepatic disease. Emerging clinical data suggest that chronic HCV infection can lead to many direct and indirect effects on the lung.Objectives: This article discusses evidence on the relationship between HCV infection and PULMONARY FIBROSIS to increase knowledge on this topic among clinicians and scientists and highlights the need for further study. Methods: We searched the MEDLINE, ISI WEB OF KNOWLEDGE, OVID, ELSEVIER, and MDCONSULT databases and top respiratory journals, such as the American Journal of Respiratory and Critical Care, Chest, and Thorax for articles in English using the following keywords: HEPATITIS C, HCV infection, IPF, PULMONARY FIBROSIS, and interstitial pneumonitis. We reviewed the reference lists of all identified studies.Results: The evidence for a pathogenetic link between PULMONARY FIBROSIS and HCV is: the higher frequency of HCV markers in IPF patients, an increase in lymphocyte and neutrophil numbers in bronchoalveolar lavage of chronic HCV infection patients, and the development of IPF in HCV-related chronic hepatitis that is treated with interferon. There is a discrepancy between studies on the frequency of HCV in IPF patients, which might be attributed to geographical differences of in the prevalence of HCV infection, selection bias in choosing the control group, and the HCV genome.Conclusions: BAL studies in HCV infection are associated with increased counts of lymphocytes and neutrophils in BAL fluid. These studies show that HCV infection is associated with nonspecific pulmonary inflammatory reactions that are not compatible with IPF but that it can lead to PULMONARY FIBROSIS. The other factor is interferon therapy. Interstitial pneumonia and sarcoidosis are well-documented complications of IFN therapy. More extensive cohort studies should be conducted to confirm an actual causal relationship between HCV infection and PULMONARY FIBROSIS.

Cites

No record.

References

No record.

Cite

APA: Copy

ALIANNEZHAD, R., & GHANEEI, MOSTAFA. (2011). HEPATITIS C AND PULMONARY FIBROSIS. HEPATITIS MONTHLY, 11(2 (31)), 71-73. SID. https://sid.ir/paper/306349/en

Vancouver: Copy

ALIANNEZHAD R., GHANEEI MOSTAFA. HEPATITIS C AND PULMONARY FIBROSIS. HEPATITIS MONTHLY[Internet]. 2011;11(2 (31)):71-73. Available from: https://sid.ir/paper/306349/en

IEEE: Copy

R. ALIANNEZHAD, and MOSTAFA GHANEEI, “HEPATITIS C AND PULMONARY FIBROSIS,” HEPATITIS MONTHLY, vol. 11, no. 2 (31), pp. 71–73, 2011, [Online]. Available: https://sid.ir/paper/306349/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops